Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes

Effects of CASQ2 mutations linked to sudden cardiac death

Dmitry Terentyev, Zuzana Kubalova, Giorgia Valle, Alessandra Nori, Srikanth Vedamoorthyrao, Radmila Terentyeva, Serge Viatchenko-Karpinski, Donald M Bers, Simon C. Williams, Pompeo Volpe, Sandor Gyorke

Research output: Contribution to journalArticle

72 Citations (Scopus)

Abstract

Cardiac calsequestrin (CASQ2) is an intrasarcoplasmic reticulum (SR) low-affinity Ca-binding protein, with mutations that are associated with catecholamine-induced polymorphic ventricular tachycardia (CPVT). To better understand how CASQ2 mutants cause CPVT, we expressed two CPVT-linked CASQ2 mutants, a truncated protein (at G112+5X, CASQ2DEL) or CASQ2 containing a point mutation (CASQ2R33Q), in canine ventricular myocytes and assessed their effects on Ca handling. We also measured CASQ2-CASQ2 variant interactions using fluorescence resonance transfer in a heterologous expression system, and evaluated CASQ2 interaction with triadin. We found that expression of CASQ2DEL or CASQ2R33Q altered myocyte Ca signaling through two different mechanisms. Overexpressing CASQ2DEL disrupted the CASQ2 polymerization required for high capacity Ca binding, whereas CASQ2R33Q compromised the ability of CASQ2 to control ryanodine receptor (RyR2) channel activity. Despite profound differences in SR Ca buffering strengths, local Ca release terminated at the same free luminal [Ca] in control cells, cells overexpressing wild-type CASQ2 and CASQ2 DEL-expressing myocytes, suggesting that a decline in [Ca] SR is a signal for RyR2 closure. Importantly, disrupting interactions between the RyR2 channel and CASQ2 by expressing CASQ2R33Q markedly lowered the [Ca]SR threshold for Ca release termination. We conclude that CASQ2 in the SR determines the magnitude and duration of Ca release from each SR terminal by providing both a local source of releasable Ca and by effects on luminal Ca-dependent RyR2 gating. Furthermore, two CPVT-inducing CASQ2 mutations, which cause mechanistically different defects in CASQ2 and RyR2 function, lead to increased diastolic SR Ca release events and exhibit a similar CPVT disease phenotype.

Original languageEnglish (US)
Pages (from-to)2037-2048
Number of pages12
JournalBiophysical Journal
Volume95
Issue number4
DOIs
StatePublished - Aug 15 2008
Externally publishedYes

Fingerprint

Calsequestrin
Ryanodine Receptor Calcium Release Channel
Sudden Cardiac Death
Cardiac Myocytes
Mutation
Muscle Cells
Reticulum
Point Mutation
Polymerization
Canidae
Carrier Proteins
Fluorescence
Polymorphic catecholergic ventricular tachycardia
Phenotype

ASJC Scopus subject areas

  • Biophysics

Cite this

Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes : Effects of CASQ2 mutations linked to sudden cardiac death. / Terentyev, Dmitry; Kubalova, Zuzana; Valle, Giorgia; Nori, Alessandra; Vedamoorthyrao, Srikanth; Terentyeva, Radmila; Viatchenko-Karpinski, Serge; Bers, Donald M; Williams, Simon C.; Volpe, Pompeo; Gyorke, Sandor.

In: Biophysical Journal, Vol. 95, No. 4, 15.08.2008, p. 2037-2048.

Research output: Contribution to journalArticle

Terentyev, D, Kubalova, Z, Valle, G, Nori, A, Vedamoorthyrao, S, Terentyeva, R, Viatchenko-Karpinski, S, Bers, DM, Williams, SC, Volpe, P & Gyorke, S 2008, 'Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: Effects of CASQ2 mutations linked to sudden cardiac death', Biophysical Journal, vol. 95, no. 4, pp. 2037-2048. https://doi.org/10.1529/biophysj.107.128249
Terentyev, Dmitry ; Kubalova, Zuzana ; Valle, Giorgia ; Nori, Alessandra ; Vedamoorthyrao, Srikanth ; Terentyeva, Radmila ; Viatchenko-Karpinski, Serge ; Bers, Donald M ; Williams, Simon C. ; Volpe, Pompeo ; Gyorke, Sandor. / Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes : Effects of CASQ2 mutations linked to sudden cardiac death. In: Biophysical Journal. 2008 ; Vol. 95, No. 4. pp. 2037-2048.
@article{523e3aed3671406c8beb2159e9d2f577,
title = "Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: Effects of CASQ2 mutations linked to sudden cardiac death",
abstract = "Cardiac calsequestrin (CASQ2) is an intrasarcoplasmic reticulum (SR) low-affinity Ca-binding protein, with mutations that are associated with catecholamine-induced polymorphic ventricular tachycardia (CPVT). To better understand how CASQ2 mutants cause CPVT, we expressed two CPVT-linked CASQ2 mutants, a truncated protein (at G112+5X, CASQ2DEL) or CASQ2 containing a point mutation (CASQ2R33Q), in canine ventricular myocytes and assessed their effects on Ca handling. We also measured CASQ2-CASQ2 variant interactions using fluorescence resonance transfer in a heterologous expression system, and evaluated CASQ2 interaction with triadin. We found that expression of CASQ2DEL or CASQ2R33Q altered myocyte Ca signaling through two different mechanisms. Overexpressing CASQ2DEL disrupted the CASQ2 polymerization required for high capacity Ca binding, whereas CASQ2R33Q compromised the ability of CASQ2 to control ryanodine receptor (RyR2) channel activity. Despite profound differences in SR Ca buffering strengths, local Ca release terminated at the same free luminal [Ca] in control cells, cells overexpressing wild-type CASQ2 and CASQ2 DEL-expressing myocytes, suggesting that a decline in [Ca] SR is a signal for RyR2 closure. Importantly, disrupting interactions between the RyR2 channel and CASQ2 by expressing CASQ2R33Q markedly lowered the [Ca]SR threshold for Ca release termination. We conclude that CASQ2 in the SR determines the magnitude and duration of Ca release from each SR terminal by providing both a local source of releasable Ca and by effects on luminal Ca-dependent RyR2 gating. Furthermore, two CPVT-inducing CASQ2 mutations, which cause mechanistically different defects in CASQ2 and RyR2 function, lead to increased diastolic SR Ca release events and exhibit a similar CPVT disease phenotype.",
author = "Dmitry Terentyev and Zuzana Kubalova and Giorgia Valle and Alessandra Nori and Srikanth Vedamoorthyrao and Radmila Terentyeva and Serge Viatchenko-Karpinski and Bers, {Donald M} and Williams, {Simon C.} and Pompeo Volpe and Sandor Gyorke",
year = "2008",
month = "8",
day = "15",
doi = "10.1529/biophysj.107.128249",
language = "English (US)",
volume = "95",
pages = "2037--2048",
journal = "Biophysical Journal",
issn = "0006-3495",
publisher = "Biophysical Society",
number = "4",

}

TY - JOUR

T1 - Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes

T2 - Effects of CASQ2 mutations linked to sudden cardiac death

AU - Terentyev, Dmitry

AU - Kubalova, Zuzana

AU - Valle, Giorgia

AU - Nori, Alessandra

AU - Vedamoorthyrao, Srikanth

AU - Terentyeva, Radmila

AU - Viatchenko-Karpinski, Serge

AU - Bers, Donald M

AU - Williams, Simon C.

AU - Volpe, Pompeo

AU - Gyorke, Sandor

PY - 2008/8/15

Y1 - 2008/8/15

N2 - Cardiac calsequestrin (CASQ2) is an intrasarcoplasmic reticulum (SR) low-affinity Ca-binding protein, with mutations that are associated with catecholamine-induced polymorphic ventricular tachycardia (CPVT). To better understand how CASQ2 mutants cause CPVT, we expressed two CPVT-linked CASQ2 mutants, a truncated protein (at G112+5X, CASQ2DEL) or CASQ2 containing a point mutation (CASQ2R33Q), in canine ventricular myocytes and assessed their effects on Ca handling. We also measured CASQ2-CASQ2 variant interactions using fluorescence resonance transfer in a heterologous expression system, and evaluated CASQ2 interaction with triadin. We found that expression of CASQ2DEL or CASQ2R33Q altered myocyte Ca signaling through two different mechanisms. Overexpressing CASQ2DEL disrupted the CASQ2 polymerization required for high capacity Ca binding, whereas CASQ2R33Q compromised the ability of CASQ2 to control ryanodine receptor (RyR2) channel activity. Despite profound differences in SR Ca buffering strengths, local Ca release terminated at the same free luminal [Ca] in control cells, cells overexpressing wild-type CASQ2 and CASQ2 DEL-expressing myocytes, suggesting that a decline in [Ca] SR is a signal for RyR2 closure. Importantly, disrupting interactions between the RyR2 channel and CASQ2 by expressing CASQ2R33Q markedly lowered the [Ca]SR threshold for Ca release termination. We conclude that CASQ2 in the SR determines the magnitude and duration of Ca release from each SR terminal by providing both a local source of releasable Ca and by effects on luminal Ca-dependent RyR2 gating. Furthermore, two CPVT-inducing CASQ2 mutations, which cause mechanistically different defects in CASQ2 and RyR2 function, lead to increased diastolic SR Ca release events and exhibit a similar CPVT disease phenotype.

AB - Cardiac calsequestrin (CASQ2) is an intrasarcoplasmic reticulum (SR) low-affinity Ca-binding protein, with mutations that are associated with catecholamine-induced polymorphic ventricular tachycardia (CPVT). To better understand how CASQ2 mutants cause CPVT, we expressed two CPVT-linked CASQ2 mutants, a truncated protein (at G112+5X, CASQ2DEL) or CASQ2 containing a point mutation (CASQ2R33Q), in canine ventricular myocytes and assessed their effects on Ca handling. We also measured CASQ2-CASQ2 variant interactions using fluorescence resonance transfer in a heterologous expression system, and evaluated CASQ2 interaction with triadin. We found that expression of CASQ2DEL or CASQ2R33Q altered myocyte Ca signaling through two different mechanisms. Overexpressing CASQ2DEL disrupted the CASQ2 polymerization required for high capacity Ca binding, whereas CASQ2R33Q compromised the ability of CASQ2 to control ryanodine receptor (RyR2) channel activity. Despite profound differences in SR Ca buffering strengths, local Ca release terminated at the same free luminal [Ca] in control cells, cells overexpressing wild-type CASQ2 and CASQ2 DEL-expressing myocytes, suggesting that a decline in [Ca] SR is a signal for RyR2 closure. Importantly, disrupting interactions between the RyR2 channel and CASQ2 by expressing CASQ2R33Q markedly lowered the [Ca]SR threshold for Ca release termination. We conclude that CASQ2 in the SR determines the magnitude and duration of Ca release from each SR terminal by providing both a local source of releasable Ca and by effects on luminal Ca-dependent RyR2 gating. Furthermore, two CPVT-inducing CASQ2 mutations, which cause mechanistically different defects in CASQ2 and RyR2 function, lead to increased diastolic SR Ca release events and exhibit a similar CPVT disease phenotype.

UR - http://www.scopus.com/inward/record.url?scp=50349102457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50349102457&partnerID=8YFLogxK

U2 - 10.1529/biophysj.107.128249

DO - 10.1529/biophysj.107.128249

M3 - Article

VL - 95

SP - 2037

EP - 2048

JO - Biophysical Journal

JF - Biophysical Journal

SN - 0006-3495

IS - 4

ER -